Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California.
Info & Links
CEO
Emily M. Leproust
Headquarters
681 GATEWAY BLVD. SOUTH SAN FRANCISCO, CA 94080, UNITED STATES
Twist Bioscience Corporation Common Stock Statistics
Valuation Measures
Market Capitalization2
2.24B
Enterprise Value
2.03B
Enterprise Value/EBITDA(ttm)
-11.36
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
8.14
Price to Book(mrq)
5.90
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
44.43%
Operating Margin(ttm)
-49.01%
Profit Margin(ttm)
-60.49%
Return on Equity(ttm)
-32.69%
Return on Invested Capital(ttm)
-39.58%
Return on Assets(ttm)
-25.25%
Income Statement
Revenue(ttm)
330.19M
Revenue Per Share(ttm)
5.54
Gross Profit(ttm)
147.23M
EBITDA(ttm)3
-178.86M
Net Income Available to Common(ttm)
-197.31M
Diluted EPS(ttm)
-3.38
Share Statistics
Beta (5Y Monthly)
1.87
52-Week Change
28.74%
S&P 500 52-Week Change
6.35%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
59.65M
Dividend Yield
0.00%
Float4
57.86M
% Held by Insiders
3.01%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
270.83M
Total Cash Per Share(mrq)
4.54
Total Debt(mrq)
15.00M
Total Debt/Equity(mrq)
3.29%
Current Ratio(mrq)
4.96%
Quick Ratio(mrq)
4.62%
Book Value Per Share(mrq)
7.65
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.36
Free Cash Flow(ytd)
-23.70M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.